Last reviewed · How we verify
NCT04916496
Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical Activity
NA trial testing Acceptance and Commitment Therapy-based lifestyle counselling programme in Schizophrenia Spectrum and Other Psychotic Disorders in 72 participants. Completed in 28 February 2024.
31 August 2023
Quick facts
| Lead sponsor | Chinese University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 72 |
| Start date | 14 June 2021 |
| Primary completion | 31 August 2023 |
| Estimated completion | 28 February 2024 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Acceptance and Commitment Therapy-based lifestyle counselling programme
- Healthy lifestyle talk
Conditions studied
- Schizophrenia Spectrum and Other Psychotic Disorders — all drugs for Schizophrenia Spectrum and Other Psychotic Disorders →
Sponsor
Chinese University of Hong Kong
Who can join
18 and older, any sex, with Schizophrenia Spectrum and Other Psychotic Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot randomized controlled trial aims to determine the feasibility, acceptability and preliminary effects of an Acceptance and Commitment Therapy-based Lifestyle Counselling Programme (ACT-LCP) on the physical and psychosocial health outcomes of patients with early psychosis over a 12-week follow-up.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Acceptance and Commitment Therapy-based Lifestyle Counselling Program for people with early psychosis on physical activity: A pilot randomized controlled trial.
Chong YY, Chien WT, Mou H, Ip CK, et al · · 2025 · cited 2× · PMID 39612765 · DOI 10.1016/j.schres.2024.11.007
Verify or expand the search:
- PubMed search for NCT04916496
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Schizophrenia Spectrum and Other Psychotic Disorders
Currently open trials in the same condition.
- NCT06673966 — Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia · recruiting
- NCT06505564 — VR-based Avatar Therapy for Treatment of Auditory Hallucinations · NA · recruiting
- NCT05951660 — Sex, Psychopharmacology, and Diabetes · NA · recruiting
- NCT05877716 — EPI-MINN: Targeting Cognition and Motivation - National · NA · active not recruiting
- NCT05622201 — A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults · Phase 2 · recruiting
Other Chinese University of Hong Kong trials
Trials by the same sponsor.
- NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
- NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
- NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
- NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
- NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04916496 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
- Last refreshed: 20 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04916496.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing